Daniel Layish is a Respiratory physician. OpenAlex indexes 16 publications with 661 citations (h-index 9).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
1115 E. Ridgewood Street
Orlando, FL 32803
Telephone
407-841-1100Provider last certified this registry record 1 Dec 2021.
Industry payments
50 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Lilly USA, LLCProgram year20252 payments
- Insmed, Inc.Program year202515 payments
- Actelion Pharmaceuticals US, Inc.Program year20257 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
53.2%Corticosteroid18.8%Trelegy Ellipta46%Symbicort16%Breo Ellipta13%Fluticasone Propionate8%Breztri Aerosphere5%Dulera3%Pulmicort Flexhaler3%Breyna2%Arnuity Ellipta2%Budesonide-Formoterol Fumarate2%Part D<11 patientsbeta2-Adrenergic Agonist12.5%Albuterol Sulfate Hfa87%Ventolin Hfa13%Part D≥184 patients+ 6 more classes in this area
Metabolism & gastrointestinal
13%Antidiarrheal microorganisms5.1%Zenpep46%Creon33%Pertzye21%Part D<11 patientsProton pump inhibitor3.9%Pantoprazole Sodium54%Omeprazole32%Dexlansoprazole Dr15%Part D<11 patients+ 4 more classes in this area
Nervous system
12.9%Benzodiazepine2.3%Alprazolam61%Clonazepam39%Part D<11 patientsgamma-Aminobutyric Acid A Receptor Positive Modulator1.8%Zolpidem Tartrate100%Part D≥18 patients+ 14 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
Similar KOLs
Other experts from the same institution or the same specialty.
Tim Driscoll
The University of Sydney
Francesco Saverio Violante
IRCCS Azienda Ospedliero-Universitaria di Bologna Policlinico di Sant'Orsola
Mark A. Rubin
University of Bern
Marc Humbert
Inserm
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”